Ly-364947,
396129-53-6,
LY-364947,
LY364947,
4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline,
4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE,
HTS 466284,
TbetaR-I Inhibitor,
LY 364947,
ALK5 Inhibitor I,
HTS-466284,
TGF-beta RI Kinase Inhibitor,
4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline,
CHEMBL261454,
4-(5-pyridin-2-yl-1H-pyrazol-4-yl)quinoline,
4-(3-pyridin-2-yl)(1h)-pyrazol-4-yl quinoline,
MFCD00800758,
AK-35014,
Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor,
4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline,
[3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole,
4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline,
4-[5-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline,
Quinoline, 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-,
PY1,
SR-01000385325,
1py5,
AC1L9LFY,
Peakdale1_000394,
SCHEMBL373665,
GTPL6050,
BDBM21492,
CHEBI:91198,
CHEBI:92118,
CTK1B3814,
HMS519B20,
AOB6754,
DTXSID90332266,
EX-A133,
HMS2043N21,
HMS3229M09,
HMS3269P09,
HMS3648O10,
HMS3677D10,
BCP05350,
KS-00001D6O,
ZX-AT000925,
IN1053,
OR7811,
s2805,
ZINC15894680,
AKOS015854224,
AKOS025394671,
AKOS026750326,
BCP9000886,
CCG-206795,
CS-3451,
DB03921,
PS-7269,
RL03518,
SB19489,
NCGC00167839-01,
4CA-0791,
AC-30262,
AJ-67976,
AJ-67977,
BC600607,
HY-13462,
AX8136899,
FT-0676988,
X5937,
EC-000.2417,
4-(3-pyridin-2-yl)-1h-pyrazol-4-ylquinoline,
A13446,
Z-3279,
LY-364947, >=98% (HPLC),
I08-901,
[3-(pyridin-2-yl)-4-(4-quinolinyl)]-1h-pyrazole,
J-513403,
SR-01000385325-1,
SR-01000385325-2,
4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]??-quinoline,
BRD-K06234293-001-01-8,
D00SXR,
D0XB4P,
cc-654,
SM305,
C17H12N4,
CID447966,
HTS466284,
B2287,
C506615,
C520284,